MyAV·¶

Professors Rob Howard (MyAV·¶ Psychiatry) and John Hardy (MyAV·¶ Queen Square Institute of Neurology) say that it is looking like the once-promising amyloid drugs won’t be the gamechanger for dementia treatments previously hoped for.